Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Safety and immunogenicity of Helicobacter pylori clinical isolates in healthy volunteers.
/ RecruitingNot Applicable Reinfection Potential of Helicobacter pylori Pilot Study
100 Clinical Results associated with Ondek Pty Ltd.
0 Patents (Medical) associated with Ondek Pty Ltd.
100 Deals associated with Ondek Pty Ltd.
100 Translational Medicine associated with Ondek Pty Ltd.